Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study

por Yu, Pengfei, Du, Yian, Xu, Zhiyuan, Huang, Ling, Cheng, Xiangdong
Publicado 2019

Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer

por Yu, Pengfei, Du, Yian, Cheng, Xiangdong, Yu, Qiming, Huang, Ling, Dong, Ruizeng
Publicado 2014

Prognostic and predictive value of metastatic lymph node ratio in stage III gastric cancer after D2 nodal dissection

por Chen, Yinbo, Li, Cong, Du, Yian, Xu, Qi, Ying, Jieer, Luo, Cong
Publicado 2017

Management Of Synchronous Krukenberg Tumors From Gastric Cancer: a Single-center Experience

por Yan, Dingding, Du, Yian, Dai, Gaiguo, Huang, Ling, Xu, Qi, Yu, Pengfei
Publicado 2018

Treatment strategy and prognostic factors for Krukenberg tumors of gastric origin: report of a 10-year single-center experience from China

por Yu, Pengfei, Huang, Ling, Cheng, Guoping, Yang, Litao, Dai, Gaiguo, Ying, Jieer, Du, Yian
Publicado 2017

Treatment of Synchronous Liver Metastases from Gastric Cancer: A Single-Center Study

por Yu, Pengfei, Zhang, Yanqiang, Ye, Zeyao, Chen, Xiangliu, Huang, Ling, Du, Yian, Cheng, Xiangdong
Publicado 2020

Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective...

por Yu, Pengfei, Ye, Zeyao, Dai, Gaiguo, Zhang, Yanqiang, Huang, Ling, Du, Yian, Cheng, Xiangdong
Publicado 2020

Prediction of Peritoneal Cancer Index and Prognosis in Peritoneal Metastasis of Gastric Cancer Using NLR-PLR-DDI Score: A Retrospective Study

por Ye, Zeyao, Yu, Pengfei, Cao, Yang, Chai, Tengjiao, Huang, Sha, Cheng, Xiangdong, Du, Yian
Publicado 2022

A Novel Method for Dynamically Assessing the Prognosis of Patients with pT1 Gastric Cancer: A Large Population-Based Dynamic Prognostic Analysis

por Pan, Siwei, Cao, Mengxuan, Hu, Can, Zhang, Yanqiang, Du, Yian, Xu, Zhiyuan, Cheng, Xiangdong
Publicado 2023

HAND2-AS1 Inhibits Gastric Adenocarcinoma Cells Proliferation and Aerobic Glycolysis via miRNAs Sponge

por Xu, Zhiyuan, Lv, Hang, Wang, Yiping, Hu, Can, Chen, Shangqi, Du, Yian, Shi, Chengwei, Cheng, Xiangdong
Publicado 2020

Hyperthermic intraperitoneal chemotherapy (HIPEC) plus systemic chemotherapy versus systemic chemotherapy alone in locally advanced gastric cancer after D2 radical resection: a ran...

por Yu, Pengfei, Huang, Xingmao, Huang, Ling, Dai, Gaiguo, Xu, Qi, Fang, Jingquan, Ye, Zeyao, Chai, Tengjiao, Du, Yian
Publicado 2023

Peritoneal metastatic gastric carcinoma cells exhibit more malignant behavior when co-cultured with HMrSV5 cells

por Wang, Lijing, Xu, Zhiyuan, Hu, Can, Chen, Shangqi, Du, Yian, Huang, Ling, Shi, Chengwei, Mo, Shaowei, Cheng, Xiangdong
Publicado 2020

Trastuzumab in combination with chemotherapy for HER2-positive metastatic gastric cancer patients underwent conversion therapy

por Zhang, Yanqiang, Xu, Xiaoqing, Hu, Can, Du, Yian, Ding, Guangyu, Chen, Jiahui, Zhu, Xiu, Xu, Zhiyuan, Wei, Qing
Publicado 2022

Efficacy of chemotherapy combined with surgical resection for gastric cancer with synchronous ovarian metastasis: A propensity score matching analysis

por Fang, Jingquan, Huang, Xingmao, Chen, Xiangliu, Xu, Qi, Chai, Tengjiao, Huang, Ling, Chen, Han, Chen, Hang, Ye, Zeyao, Du, Yian, Yu, Pengfei
Publicado 2023

SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score–matched analysis

por Huang, Xingmao, Fang, Jingquan, Huang, Ling, Chen, Hang, Chen, Han, Chai, Tengjiao, Ye, Zeyao, Chen, Hanguang, Xu, Qi, Du, Yian, Yu, Pengfei
Publicado 2023

Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial

por Xu, Zhiyuan, Hu, Can, Yu, Jianfa, Du, Yian, Hu, Ping, Yu, Guofa, Hu, Conggang, Zhang, Yu, Mao, Wei, Chen, Shanqi, Cheng, Xiangdong
Publicado 2021

Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a ran...

por Shen, Jinwen, Zhu, Xiu, Du, Yian, Zhu, Yuan, Yu, Pengfei, Yang, Litao, Xu, Zhiyuan, Huang, Ling, Zhang, Yunli, Zhang, Yanqiang, Liu, Luying, Cheng, Xiangdong
Publicado 2021

Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors

por Wang, Deqiang, Chen, Xiaofeng, Du, Yian, Li, Xiaoqin, Ying, Leqian, Lu, Yi, Shen, Bo, Gao, Xuan, Yi, Xin, Xia, Xuefeng, Sui, Xinbing, Shu, Yongqian
Publicado 2022

Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, pr...

por Cui, Yuehong, Yu, Yiyi, Zheng, Song, Ying, Jie’er, Du, Yi’an, Wang, Yan, Wang, Xuefei, Shen, Zhenbin, Liu, Fenglin, Lv, Minzhi, Sun, Yihong, Liu, Tianshu
Publicado 2023

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III m...

por Cheng, Xiangdong, Wu, Dan, Xu, Nong, Chen, Luchuan, Yan, Zhilong, Chen, Ping, Zhou, Lei, Yu, Jianfa, Cui, Jiuwei, Li, Wei, Wang, Chang, Feng, Wenming, Wei, Yunhai, Yu, Pengfei, Du, Yian, Ying, Jieer, Xu, Zhiyuan, Yang, Litao, Zhang, Yunli
Publicado 2021